Bengaluru Startup ImmunitoAI Uses Artificial Intelligence to Develop Next-Generation Antibody Medicines
Founded in 2020 by Dr. Aridni Shah and Trisha Chatterjee, ImmunitoAI is part of India’s emerging technology-driven biotechnology ecosystem. The company focuses on designing antibody candidates with specific biological and pharmaceutical properties rather than relying exclusively on conventional laboratory screening methods.